HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

desmethoxyfallypride

structure given in first source

Also Known As:

(18)F-desmethoxyfallypride

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Salicylamides: 2
    - desmethoxyfallypride: 4

Experts

1.	Meyer, Philipp T: 2 articles (10/2012 - 10/2012)
2.	Weber, Wolfgang A: 2 articles (10/2012 - 10/2012)
3.	Bartenstein, Peter: 2 articles (04/2010 - 08/2004)
4.	Amtage, Florian: 1 article (10/2012)
5.	Braun, Friederike: 1 article (10/2012)
6.	Döbrössy, Máté D: 1 article (10/2012)
7.	Garcia, Joanna: 1 article (10/2012)
8.	Hellwig, Bernhard: 1 article (10/2012)
9.	Hellwig, Sabine: 1 article (10/2012)
10.	Klein, Stefanie: 1 article (10/2012)

Related Diseases

1.	Parkinsonian Disorders (Parkinsonism) 10/01/2012 - "Fourteen patients with parkinsonian syndromes underwent (18)F-desmethoxyfallypride PET over 90 min. Volume-of-interest analyses were performed after spatial normalization, with the right and left caudate nuclei and putamina as target regions and the cerebellum as reference region. " 10/01/2012 - "Assessment of striatal dopamine receptor availability with (18)F-desmethoxyfallypride PET is of high diagnostic utility in parkinsonism. " 04/01/2010 - "We evaluated the utility of the selective dopamine D(2/3) receptor ligand (18)F-desmethoxyfallypride ((18)F-DMFP) for the differential diagnosis of patients with idiopathic parkinsonian syndrome (IPS) and nonidiopathic parkinsonian syndrome (non-IPS). " 08/01/2004 - "The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism."
2.	Neurodegenerative Diseases (Neurodegenerative Disease) 10/01/2012 - "[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases."

Related Drugs and Biologics

1.	Ligands
2.	Dopamine (Intropin)
3.	Dopamine D2 Receptors (Dopamine D2 Receptor)
4.	Dopamine Receptors (Dopamine Receptor)